Company Filing History:
5 out of 4,770 
1 out of 2,198 
1 out of 2,405 
Years Active: 2003-2011
Title: Innovations of Xin-Min Wang
Introduction
Xin-Min Wang is a notable inventor based in Schwenksville, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of vaccines and pharmaceutical compositions. With a total of 7 patents, his work has had a profound impact on immunoprophylaxis against papillomavirus infections.
Latest Patents
One of his latest patents focuses on the optimized expression of HPV 58 L1 in yeast. This invention provides synthetic DNA molecules encoding the HPV58 L1 protein, which are codon-optimized for high-level expression in yeast cells. The synthetic molecules can be utilized to produce HPV58 virus-like particles (VLPs), which are essential for creating effective vaccines and pharmaceutical compositions. These vaccines offer immunoprophylaxis against papillomavirus infections through neutralizing antibody and cell-mediated immunity, and they are also beneficial for treating existing HPV infections.
Career Highlights
Throughout his career, Xin-Min Wang has worked with prominent companies in the pharmaceutical industry, including Merck & Company, Inc. and SmithKline Beecham Corporation. His experience in these organizations has contributed to his expertise in vaccine development and biotechnology.
Collaborations
Xin-Min Wang has collaborated with esteemed colleagues such as Kathrin Ute Jansen and William L McClements. These partnerships have further enhanced his research and innovation in the field.
Conclusion
Xin-Min Wang's contributions to biotechnology and vaccine development are noteworthy. His innovative patents and collaborations reflect his commitment to advancing medical science and improving public health.